Insiders · KLRS

KLRS insider transactions

Kalaris Therapeutics Inc. (KLRS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KLRS

• 33d
  SEC Form 4 filed by Hagen Brett R

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 36d
  SEC Form 4 filed by Oxtoby Andrew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 36d
  SEC Form 4 filed by Gall Matthew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 36d
  SEC Form 4 filed by Feinsod Matthew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 67d
  Director Akkaraju Srinivas bought $5,000,006 worth of shares (479,847 units at $10.42) (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 124d
  Director Akkaraju Srinivas was granted 1,500,000 shares (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 173d
  SEC Form 4 filed by Chief Financial Officer Gall Matthew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 173d
  SEC Form 3 filed by new insider Gall Matthew

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Patel Samir Chandrakant

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Jovan-Embiricos Morana

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Akkaraju Srinivas

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Chief Accounting Officer Hagen Brett R

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Ferrara Napoleone

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Officer Oxtoby Andrew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Adamis Anthony P

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Chief Medical Officer Feinsod Matthew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Patterson Leone D

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 379d
  SEC Form 4 filed by Director Hallal David

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 386d
  SEC Form 3 filed by new insider Patterson Leone D

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)